The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

A TMT test, or treadmill test, evaluates heart function during exercise to detect heart conditions.

Individuals experiencing chest pain, at risk for heart disease, or preparing for cardiac evaluation.

Patients walk on a treadmill while heart rate, blood pressure, and ECG are monitored.

Yes, it is supervised by cardiologists to ensure safety during exercise.

It suggests insufficient blood flow to the heart during exercise, indicating possible coronary artery disease.

The ABG Test measures oxygen, carbon dioxide, and other gases in the blood to evaluate lung function and acid-base balance.

A blood sample is collected from an artery, typically in the wrist or arm, using a needle.

No special preparation is required, but avoid smoking or strenuous exercise before the test. Inform your doctor about any medications you are taking.

Results are usually available within a few hours of the test, allowing for prompt diagnosis and treatment.

Discuss any abnormal results with your healthcare provider for appropriate interpretation and to determine the next steps for treatment or further testing.